AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

OncoHost, a technology company transforming the approach to precision medicine for improved cancer patient outcomes, today announced its acceptance to present a scientific poster at the American ...

CatalYm today announced the presentation of the first preclinical data demonstrating that the company’s clinical-stage ...

University of Kentucky Markey Cancer Center researchers will present their latest scientific advancements at the American ...

Additionally, in the framework of a licensing agreement and a collaborative endeavor to support innovative research, Debiopharm and Oncodesign Services will present promising new data illustrating how ...

In the 22Rv1 model, OP-3136 inhibited tumor growth in a dose-dependent manner and, when combined with docetaxel, resulted in enhanced anti-tumor activity. These data indicate OP-3136 may be effective ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing ...

Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardiac, renal, and metabolic diseases, today announced that a poster ...

and bioinformatic analysis on rare sinonasal cancer samples provided by D3b. “We hope that this partnership represents a significant step forward in our understanding of the genetic ...

Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from target discovery to clinical development ...